Product Information
ATORVASTATIN 40 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0374 per EA under NDC 67877051305. Its NADAC has been published 372 times since Aug 21, 2019.
FDA first approved this application on Dec 21, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877051305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209288FDA Approved
12/21/2018
TE Code
AB
On Market Since
12/23/2018
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 372 times since Aug 21, 2019, and over the history we have for it it has declined 61.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0374 per EA |
|---|---|
| All-time high | $0.0970 (Sep 11, 2019) |
| All-time low | $0.0370 (Aug 19, 2026) |
| 52-week high | $0.0426 |
| 52-week low | $0.0370 |
| Median price | $0.0597 |
| Average price | $0.0608 |
| Largest weekly change | +27.7% (Aug 21, 2024) |
| Weeks tracked | 372 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atorvastatin Calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0374 per EA (NDC 67877051305), effective Sep 30, 2026.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 61.4%. It has been tracked across 372 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Aug 21, 2019, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0370 (Aug 19, 2026) to a high of $0.0970 (Sep 11, 2019), with a median of $0.0597 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 67877051305) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.